Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2
Clinical trial NCT01593020 · COMPLETED
Trial details
- NCT number
- NCT01593020
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-03
- Primary completion
- 2020-11-04
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.